Your browser doesn't support javascript.
loading
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy.
Huang, Daniel Q; Muthiah, Mark D; Zhou, Lei; Jumat, Halisah; Tan, Wan Xin; Lee, Guan Huei; Lim, Seng Gee; Kow, Alfred; Bonney, Glenn; Shridhar, Iyer; Lim, Yi Ting; Wee, Aileen; Pang, Yin Huei; Soon, Gwyneth; Chow, Pierce; Dan, Yock Young.
Afiliação
  • Huang DQ; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Muthiah MD; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Zhou L; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Jumat H; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Tan WX; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Lee GH; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Lim SG; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Kow A; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System, Singapore.
  • Bonney G; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System, Singapore.
  • Shridhar I; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System, Singapore.
  • Lim YT; Department of Diagnostic Imaging, National University Health System, Singapore.
  • Wee A; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, National University Hospital, National University Health System, Singapore.
  • Pang YH; Department of Pathology, National University Hospital, National University Health System, Singapore.
  • Soon G; Department of Pathology, National University Hospital, National University Health System, Singapore.
  • Chow P; Division of Surgical Oncology, National Cancer Center Singapore, Singapore; Department of Hepato-Pancreato-Biliary and Transplant Surgery, Singapore General Hospital, Singapore; Duke-NUS Medical School Singapore, Singapore.
  • Dan YY; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: mdcdyy@nus.edu.sg.
Cell Mol Gastroenterol Hepatol ; 11(5): 1313-1325, 2021.
Article em En | MEDLINE | ID: mdl-33340714
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Modelos Animais de Doenças / Cirrose Hepática / Neoplasias Hepáticas / Neovascularização Patológica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Modelos Animais de Doenças / Cirrose Hepática / Neoplasias Hepáticas / Neovascularização Patológica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos